White Paper

Bulk Drug Substance Logistics – Primary Packaging

Plastic Bottles — Widemouth

It has become standard procedure to geographically detach the processing of biopharmaceutical substances from production of the final medicinal drug product: Large batches of the active ingredient are being manufactured at one location; the ingredient is then divided into many smaller frozen units that are shipped to various sites around the globe for the final processing.

Due to regulation, the life impacting nature of drugs, and their monetary value (especially in larger volumes), manufacturers are understandably cautious about adopting new technologies in sensitive operations. There are currently many options of primary packages on how to transport the drug substance from A to B.

Click here to read the complete Challenges In Bulk Drug Substance Logistics EBook

 

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: